Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort

Objectives To determine the prevalence of eosinophilia in patients with recent-onset arthritis suggestive of rheumatoid arthritis (RA) and to describe their features and outcomes.Methods We performed an ancillary study of data from a French prospective multicentre cohort study monitoring clinical, l...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandrine Jousse-Joulin, Alain Saraux, Thierry Marhadour, Divi Cornec, Gilles Chiocchia, Valérie Devauchelle-Pensec, Gabriel J Tobón, Dewi Guellec, Morgane Milin, Olivier Vittecocq
Format: Article
Language:English
Published: BMJ Publishing Group 2015-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/1/1/e000070.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206925476757504
author Sandrine Jousse-Joulin
Alain Saraux
Thierry Marhadour
Divi Cornec
Gilles Chiocchia
Valérie Devauchelle-Pensec
Gabriel J Tobón
Dewi Guellec
Morgane Milin
Olivier Vittecocq
author_facet Sandrine Jousse-Joulin
Alain Saraux
Thierry Marhadour
Divi Cornec
Gilles Chiocchia
Valérie Devauchelle-Pensec
Gabriel J Tobón
Dewi Guellec
Morgane Milin
Olivier Vittecocq
author_sort Sandrine Jousse-Joulin
collection DOAJ
description Objectives To determine the prevalence of eosinophilia in patients with recent-onset arthritis suggestive of rheumatoid arthritis (RA) and to describe their features and outcomes.Methods We performed an ancillary study of data from a French prospective multicentre cohort study monitoring clinical, laboratory and radiographic data in patients with inflammatory arthritis of 6 weeks to 6 months duration. We determined the proportion of patients with eosinophilia, defined as a count >500/mm3, at baseline and after 3 years. Features of patients with and without baseline eosinophilia were compared.Results Baseline eosinophilia was evidenced in 26 of 804 (3.2%) patients; their mean eosinophil count was 637.7±107/mm3. Baseline eosinophilia was ascribed to atopic syndrome in 6 of 26 (23.1%) patients. After 3 years, patients with eosinophilia had higher Health Assessment Questionnaire scores (0.9 vs 0.5, p=0.004), higher patient visual analogue scale activity score and morning stiffness intensity (p=0.05), and were more often taking disease-modifying antirheumatic drugs (p=0.02). Baseline eosinophilia was not associated with presence of extra-articular manifestations.Conclusions Eosinophilia is rare in recent-onset arthritis suggestive of RA, and is usually directly related to the rheumatic disease. Our data suggest that patients with mild eosinophilia at diagnosis could respond worse to the treatment than those without.
format Article
id doaj-art-14f9e10541854949bb2f9e1cbfe134ae
institution Kabale University
issn 2056-5933
language English
publishDate 2015-07-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-14f9e10541854949bb2f9e1cbfe134ae2025-02-07T01:40:11ZengBMJ Publishing GroupRMD Open2056-59332015-07-011110.1136/rmdopen-2015-000070Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohortSandrine Jousse-Joulin0Alain Saraux1Thierry Marhadour2Divi Cornec3Gilles Chiocchia4Valérie Devauchelle-Pensec5Gabriel J Tobón6Dewi Guellec7Morgane Milin8Olivier Vittecocq9LBAI, Univ Brest, Inserm, Brest, France, Brest, FranceDepartment of Rheumatology, Hopital Cavale Blanche, Brest, FranceRheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU Brest, Brest, FranceU1227, LBAI, Univ Brest, Inserm, and CHU Brest, Brest, France, Brest, France3University Paris Diderot, Sorbonne Paris Cité, INFLAMEX, Laboratoire d’Excellence, Paris, FranceRheumatology, Brest University and La Cavale Blanche Hospital, Brest, FranceDepartment of Internal Medicine, Division of Rheumatology, Fundación Valle del Lili, ICESI University School of Medicine, Cali, ColumbiaRheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU Brest, Brest, FranceDepartment of Rheumatology, CHU de la Cavale Blanche, Boulevard Tanguy Prigent, Brest, FranceRhumatologie & Inserm, U905 (IRIB) CIC 1404, CHU Hôpitaux de Rouen, Rouen, FranceObjectives To determine the prevalence of eosinophilia in patients with recent-onset arthritis suggestive of rheumatoid arthritis (RA) and to describe their features and outcomes.Methods We performed an ancillary study of data from a French prospective multicentre cohort study monitoring clinical, laboratory and radiographic data in patients with inflammatory arthritis of 6 weeks to 6 months duration. We determined the proportion of patients with eosinophilia, defined as a count >500/mm3, at baseline and after 3 years. Features of patients with and without baseline eosinophilia were compared.Results Baseline eosinophilia was evidenced in 26 of 804 (3.2%) patients; their mean eosinophil count was 637.7±107/mm3. Baseline eosinophilia was ascribed to atopic syndrome in 6 of 26 (23.1%) patients. After 3 years, patients with eosinophilia had higher Health Assessment Questionnaire scores (0.9 vs 0.5, p=0.004), higher patient visual analogue scale activity score and morning stiffness intensity (p=0.05), and were more often taking disease-modifying antirheumatic drugs (p=0.02). Baseline eosinophilia was not associated with presence of extra-articular manifestations.Conclusions Eosinophilia is rare in recent-onset arthritis suggestive of RA, and is usually directly related to the rheumatic disease. Our data suggest that patients with mild eosinophilia at diagnosis could respond worse to the treatment than those without.https://rmdopen.bmj.com/content/1/1/e000070.full
spellingShingle Sandrine Jousse-Joulin
Alain Saraux
Thierry Marhadour
Divi Cornec
Gilles Chiocchia
Valérie Devauchelle-Pensec
Gabriel J Tobón
Dewi Guellec
Morgane Milin
Olivier Vittecocq
Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
RMD Open
title Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
title_full Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
title_fullStr Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
title_full_unstemmed Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
title_short Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
title_sort eosinophilia predicts poor clinical outcomes in recent onset arthritis results from the espoir cohort
url https://rmdopen.bmj.com/content/1/1/e000070.full
work_keys_str_mv AT sandrinejoussejoulin eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT alainsaraux eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT thierrymarhadour eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT divicornec eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT gilleschiocchia eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT valeriedevauchellepensec eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT gabrieljtobon eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT dewiguellec eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT morganemilin eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort
AT oliviervittecocq eosinophiliapredictspoorclinicaloutcomesinrecentonsetarthritisresultsfromtheespoircohort